Pfizer Raises Outlook Amid Strong Demand for Non-Covid Products
Wall Street Journal
The drugmaker’s quarterly results beat Wall Street estimates and the drugmaker raised its outlook, denoting strong demand for its non-Covid products.
Wall Street Journal
The drugmaker’s quarterly results beat Wall Street estimates and the drugmaker raised its outlook, denoting strong demand for its non-Covid products.